Get started
Channel Therapeutics CorporationCC

Channel Therapeutics Corporation

2.11USDR
−0.05−2.45%
At close at Mar 6, 21:43 GMT
USD
No trades
See on Supercharts
Overview
Financials
News Discussions Technicals Seasonals

CHRO fundamentals

Key facts

Market capitalization‪12.70 M‬USD
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)−1.73USD
Founded2002
Employees (FY)8
CEOFrancis P. Knuettel
Websitechanneltherapeutics.com
About

Channel Therapeutics Corp. is a clinical-stage biotech company that engages in the development and commercialization of new therapeutics to alleviate pain. The company was founded in 2002 and is headquartered in Freehold, NJ.

Ownership
‪‪6.03 M‬‬
Closely held shares
‪‪4.80 M‬‬ (79.64%)
Free Float shares
‪‪1.23 M‬‬ (20.36%)
Closely held shares
‪‪4.80 M‬‬ (79.64%)
Free Float shares
‪‪1.23 M‬‬ (20.36%)
Capital structure
Market cap
‪‪12.70 M‬‬
Debt
‪‪2.29 M‬‬
Cash & equivalents
‪‪1.25 M‬‬
Enterprise value
‪‪13.73 M‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪12.70 M‬‬
Price to earning ratio (P/E)
—
Price to sales ratio (P/S)
—
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
—
Price to sales ratio (P/S)
—
Valuation ratios
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24

Growth and Profitability

Company’s recent performance and margins

Performance
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−4.40 M‬‬
‪‪−3.30 M‬‬
‪‪−2.20 M‬‬
‪‪−1.10 M‬‬
‪0.00‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−2.40 M‬‬
‪‪−1.80 M‬‬
‪‪−1.20 M‬‬
‪‪−600.00 K‬‬
‪0.00‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−1.80 M‬‬
‪‪−1.35 M‬‬
‪‪−900.00 K‬‬
‪‪−450.00 K‬‬
‪0.00‬

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
Nothing to show here, yet
There are currently no revenue forecasts for this symbol.
Earnings
Next:May 28, 2025
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q1 '25
‪−0.60‬
‪−0.45‬
‪−0.30‬
‪−0.15‬
‪0.00‬
Actual
Estimate

Dividends

Dividend yield, history and sustainability

CHRO does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company

Debt level and coverage
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−4.00 M‬‬
‪‪−2.00 M‬‬
‪0.00‬
‪‪2.00 M‬‬
‪‪4.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪900.00 K‬‬
‪‪1.80 M‬‬
‪‪2.70 M‬‬
‪‪3.60 M‬‬
Assets
Liabilities